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Abstract: The COVID-19 pandemic has driven a global research to uncover novel, effective therapeu-
tical and diagnosis approaches. In addition, control of spread of infection has been targeted through
development of preventive tools and measures. In this regard, nanomaterials, particularly, those
combining two or even several constituting materials possessing dissimilar physicochemical (or even
biological) properties, i.e., nanohybrid materials play a significant role. Nanoparticulate nanohybrids
have gained a widespread reputation for prevention of viral crises, thanks to their promising antimi-
crobial properties as well as their potential to act as a carrier for vaccines. On the other hand, they
can perform well as a photo-driven killer for viruses when they release reactive oxygen species (ROS)
or photothermally damage the virus membrane. The nanofibers can also play a crucial protective
role when integrated into face masks and personal protective equipment, particularly as hybridized
with antiviral nanoparticles. In this draft, we review the antiviral nanohybrids that could potentially
be applied to control, diagnose, and treat the consequences of COVID-19 pandemic. Considering
the short age of this health problem, trivially the relevant technologies are not that many and are
handful. Therefore, still progressing, older technologies with antiviral potential are also included and
discussed. To conclude, nanohybrid nanomaterials with their high engineering potential and ability
to inactivate pathogens including viruses will contribute decisively to the future of nanomedicine
tackling the current and future pandemics.
Keywords: nanohybrid; nanocomposite; COVID-19; biomedical application
1. Introduction
December 2019 was the onset of a new coronavirus pandemic in China that was then
rapidly spread across the world. Two months later in February, the Coronavirus Study
Group (CGS) of the International Committee on Virus Taxonomy (ICTV) designated the
virus as SARS-CoV-2 and the caused disease was named as “coronoavirus disease 2019”
(COVID-19) by the Director General of the World Health Organization (WHO) [1]. In March
2020, the WHO announced that the COVID-19 outbreak is a pandemic [1]. This rapidly
spreading pandemic has affected all around the world, ending up with the infection of
~187 millions of people and the death of ~4.04 million of the infected cases (the statistics
were obtained from worldometer.info on 10 July 2021).
Cough, fever, and fatigue are the main symptoms of the coronavirus disease and
commonly seen in 68.7%, 85.6%, and 39.4% of the patients, respectively. The comorbidities
including diabetes, hypertension, and coronary heart disease have been proved to directly
affect the severity of the disease [2]. As reported lately [3–6], a number of patients suffering
from COVID-19 shows damage not only in the respiratory system but also in kidney, heart,
brain (encephalitis), and eye (conjunctivitis). Such adverse health consequences necessitate
prompt development of vaccines, drugs, and medical tools that can effectively fight COVID-
19. In this regard, nanomedicine and nanotechnology can offer many opportunities, as
have done already throughout the history of novel medicine.
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2. Biomedical Applications of Antiviral Nanomaterials
Thanks to a variety of extraordinary electrical, chemical, magnetic, and antimicrobial
properties as well as an extensive surface area/volume ratio, nanomaterials offer a diverse
range of application in relevance to the COVID-19 pandemic. Figure 1 illustrates the
biomedical applications of nanomaterials addressing different medicinal objectives such as
control, prevention, diagnosis, and treatment.
Figure 1. Biomedical applications of nanomaterials against the COVID-19 pandemic. Reproduced
with permission [7] under a Creative Commons Attribution 4.0 International License.
Hybrid (composite) materials offer a favorable collection of properties originating
from those of their distinct consituents, i.e., matrix and filler [8–10]. These properties could
be beyond the predicted, classic properties and be indeed extraordinary, particularly, when
dealing with nanofillers, as found in the nanohybrids. This field is dynamicaly growing
and has been extensively highlighted worldwide.
Within the course of the past decade, thanks to recent technological advances, nanohy-
brids have been realized in new dimensionalities (0D–3D) and new compositions (especially
involving the biological materials), Figure 2. Therefore, the definition of such advanced
materials should be updated to include a more comprehensive view on the interplay of the
constituting phases and their configuration. As a solid, ubiquitous definition, nanohybrids
are multiphasic materials that show unique properties. These properties are tailored by
the size (dimension), composition, and arrangement of the nanofillers. The latter could
be notably influenced by the structure and characteristics of the encapsulating medium
(material). In this study, we review biomedical applications of antiviral nanohybrids in rele-
vance to COVID-19 pandemic and other viral crises in several classes of control, prevention,
diagnosis, and treatment.
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Figure 2. Nanohybrid materials in different dimensionalities, forms, and configurations. (a) A
0D bionanohybrid comprised of a plasmonic nanoparticle coupled with a protein, i.e., bovine
serum albumin (BSA). (b) A 0D superparamagnetic core-shell nanohybrid composed of Au
nanoparticles/Fe3O4@SiO2 developed via chemical immobilization of Au nanoparticles on the
amino group functionalized SiO2 surface. (c) A 1D nanohybrid made of Au nanoparticle/DNA; in
this system the Au nanoparticles (10 nm) are organized as a secondary left-handed helix located on
the DNA origami bundle. The bundle per se consists of 24 parallel double helices. The magnified zone
indicates that the thiolated ssDNA functionalized Au nanoparticles are coupled to the DNA origami.
Next, functionalization of the DNA origami by the biotin groups (green) enables its attachment to
a surface coated with BSA–biotin–neutravidin (red, green, and grey, respectively). Transmission
electron microscopy (TEM) image exhibits a nanohelix mounted on a carbon-deposited grid (the scale
bar represents 50 nm). (d) A 1D nanohybrid based on protein functionalized polymer nanofibers
whereon Au nanoparticles are coupled by the protein ligands. (e) A 2D nanohybrid composed of
cobalt-reduced graphene oxide (Co-rGO) (as shown in the figure, hexavalent chromium (Cr(VI)) is
reduced by the nanohybrid). (f) A 3D hierarchical nanohybrid made of graphene–carbon nanotube–
nickel (G-CNT-Ni), meant to operate as an anode material in the fully lithiated state. Reproduced
with permission [8] Copyright 2018, Wiley-VCH.
2.1. Nanohybrid Materials Used for Control/Prevention of Viral Transmission
SARS-COV-2 is highly enduring and may attach on the surface of objects or persistently
exist in the air as aerosols. According to various reports, coronavirus can survive and stay
infectious for a sufficiently long period of time raising potential danger for spreading the
virus from one place to another and especially for crowded places such as aircraft cabin,
restaurants, and shopping centers [11]. In this regard, the main strategy to hamper the
virus person-to-person transmission is wearing the protective equipment such as masks,
gloves and protective clothing, Figure 3a. The conventional masks include the respirator
masks (N95 and P2) and the surgical (face) masks. Respirator masks are particularly
made to protect individuals against high-risk medical conditions in terms of presence of
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viruses and bacteria. Differently, surgical masks are meant to provide a lower level of such
protection [12].
Nanohybrid materials can be implemented as the building blocks of the above men-
tioned personal protective equipment (PPE) to offer hydrophobicity and antimicrobial
function, while maintaining breathability. The hydrophobicity of PPE can lead to formation
of an effective barrier against deposition of the airborne droplets originating from cough
or sneeze [11]. At the same time, Cu and Ag nanoparticles, for instance, can be applied
on the surface of the PPE products to build up an antimicrobial barrier preventing the
rapid growth of coronavirus on the surface. Moreover, the nanostructured, hybrid PPE
materials, i.e., those implementing nanofibers alongside microfibers, can decrease the
breathing resistance, thereby providing a comfortable wearing experience [11].
Recently, nanofiber based nanohybrids have been developed to improve the filtering
performance of PPE against pathogens [13]. In this regard, Ag nanoparticles, CuO, iodine
(I), titanium oxide (TiO2) with antimicrobial properties can confer the masks surfaces with
a disinfection capacity for viruses [13]. The high surface to volume ratio of nanofibers can
also enhance the capturing efficiency and provide some surface area- related phenomena
including ion exchange and catalysis [14]. For instance, the nanofibers functionalized
with chemicals and nucleating agents (e.g., o-iodosobenzoic acid (IBA) and β-cyclodextrin
(β-CD)) can decompose or deactivate the contaminant, thereby minimizing the possibility
of virus and pathogen inhale [15]. As a more sophisticated class of protective masks,
filtering face piece respirator (FFPR) shows an improved performance in terms of air flow
resistance and bacterial filtration efficiency. Such merits originate from co-presence of par-
tially gelled sub-micron polypropylene (PP), PP nanofibers, and a hydrophilic bactericidal
layer that can disinfect pathogens efficiently [16].
Figure 3. (a) airborne transmission of infectious aerosol particles is notably reduced by wearing masks. Reproduced with
permission [17], Copyright 2020, Science. (b) Operation mechanisms of fibrous face masks depending on the size of the
filtrate. (c) size (length) scale of different particles available in nature and the respective filtration means including surgical
masks, N95 respirators, and electrospun fibrous filters. Reproduced with permission [18], Copyright 2021, Elsevier.
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Apart from a high antimicrobial filtration efficiency, nanofibers can also optimize the
wearing experience and offer a fitter mask choice through better facial seal. As a (nano)hybrid
system, meltblown fibers and spunbond fibers can be combined with nanofibers through
the electrospinning technology to form a basis for a particular type of respirators [18].
The nanofiber-based filtering facepiece respirators (FFR) can effectively capture viruses or
pathogens via different mechanisms such as Brownian diffusion, because of their higher
surface to volume ratio compared to that seen in the conventional masks. Moreover, the
nanofiber FFR can be made thinner than N95 FFR, thus with higher air permeability and
better breathability, leading to enhanced wearing experience [19]. The main filtration
mechanisms of fiber-based face masks for three classes of particles in terms of size are
shown in Figure 3b. The size range of the particles discriminated by electrospun fiber
filters compared to conventional surgical masks and respirators is illustrated in Figure
3c. The face masks are designed to efficiently block macro, micro, and nanoparticles
through interception, inertial impaction, and diffusion, respectively [12]. Particularly,
inertial impaction matters most, given the size range of viruses and bacteria.
The particles smaller than 300 nm, hardly collide with the pore walls and are readily
bombarded by the surrounding air molecules. To capture these particles, electrospun
nanohybrid nanofibers have been proved to be very efficient. Xianhua et al. [20] prepared
a nanohybrid nanofiber mask based on Ag nanoparticles reinforced polyvinyl alcohol
(PVA) nanofibers through electrospinning. The as-formed nanohybrid nanofibers were
deposited on an activated carbon nonwoven fabric as the substrate. As verified in this
study, the nanohybrid protective mask is able to show an excellent performance in terms of
filterability, moisture permeability, and breathability. Such characteristics depend mainly
on the Ag nanofiller amount, so that with the increase of filling factor, the nanohybrid
nanofiber layer turns thicker and thus lowers the air permeability. On the other hand,
under same conditions, the moisture permeability increases. Zhang et al. [21] devised an
antiviral nanofibrous membrane composed of vitamin k incorporated poly(vinyl alcohol-
co-ethylene) that could show intensive photoactivity, thereby generating ROS under solar
and UVA light. As a result of such a performance, the nanofiber membrane was able to
inactivate >99.9% of viruses and thus offer a promising capacity for development of PPE
and face masks.
Apart from the use of PPEs, vaccination has ever been considered as a successful
prevention strategy. In this regard, nanomaterials as efficient carriers can transport the
vaccine into proper cellular colonies and subcellular areas. Given the size and dimension-
ality, viruses are in fact living nanomaterials and the Live Attenuated Vaccines (LAVs),
Inactivated Vaccines (IVs) and viral vectors inspired from viruses are nanotechnologies.
Performing in the same size scale as viruses, nanoparticles can play a crucial role in
the development of vaccines and thus immunoengineering [22]. Man-made and natural
nanoparticles resemble viruses in terms of structure, while biotechnology, nanochemistry,
and chemical biology synergistically enable creation of advanced vaccines that will be
incorporated therein.
DNA vaccine carriers: DNA vaccine’s working mechanism is based on inclusion of
a protein antigen’s gene in a recombinant eukaryotic expression vector (e.g., a plasmid)
and its subsequent introduction into the body to generate the exogenous antigen, driving
antigen-specific immune reactions against the disease [23]. Versus traditional vaccines,
these vaccines imitate natural infections and provoke antibody secretion as well as the cell
mediated immune reactions. Therefore, they hold promise for treatment of chronic viral
infection and cancer. Furthermore, the DNA vaccine assures reliable gene expression in
transfected host cells, thus producing enough quantity of antigen. Facile manipulation of
genetic sequences through recombinant methods, large scale production and simple storage
and transport (no need to cold-chain), the potential of induction of particular antigen and
immunoregulatory proteins, and most importantly proven safety in animal/human clinical
tests are of other advantages of the DNA vaccines [24–26]. However, such vaccines show
insufficient immunogenicity and due to enzymatic (nuclease) degradation and subsequent
Polymers 2021, 13, 2833 6 of 25
elimination through the reticular endothelial system, their in vivo half-life is quite short
(minutes) [27]. Additionally, naked DNA must be able to defeat several cellular and subcel-
lular hurdles such as the plasma membrane to induce protein expression [28]. Therefore,
efficient transportation of DNA vaccine specifically to the desired cells in different organs
and lymphoid tissues and assuring reliable, optimum gene transfection efficiency along
with induction of the maturation of the dendritic cells and presentation of antigen are
the main objectives towards the creation of DNA vaccines that could be properly met by
introduction of new, advanced biomaterial based carriers [29].
Different kinds of man-made nanocarriers such as polymeric nanoparticles and
cationic liposomes have been synthesized for the DNA vaccine delivery through cell
membranes [30]. For instance, Zhao et al. [31] designed a nanocarrier composed of poly
(lactic-co-glycolic) acid (PLGA) coated with chitosan (CS) to deliver the DNA vaccine
against Newcastle disease virus (NDV). As stated by the authors, the chitosan coated PLGA
nanocarrier of the DNA vaccine assures a higher cellular, humoral, and mucosal immune re-
sponse in a safer and efficient manner. Farris et al. [32] encapsulated DNA vaccine/chitosan
nanoparticle within a zein (ZN) microparticle and in fact devised a hybrid-dual partic-
ulate carrier to govern the DNA vaccine delivery. Routinely, the DNA vaccines that are
delivered orally target the mucosa (i.e., intestinal mucosa) to cause the mucosal immunity.
However, when the DNA vaccines pass through the gastrointestinal tract, it would be
readily disintegrated at a low pH, and by endogenous nucleases and gastric enzymes. The
designed hybrid-dual particulate carrier shows a more controlled DNA release behavior in
simulated gastric fluid (SGF) as compared to DNA/CS nanoparticles. Additionally, the
external ZN matrix degrades at specific areas and thereby leads to successful mediated
transfection of the DNA/CS nanoparticles in vitro. Eventually, the hybrid-dual particulate
carrier encoding GFP could drive the production of anti-GFP IgA antibodies, verifying
in vivo transfection and expression. Layek et al. [33] developed a DNA vaccine nanocar-
rier made of mannosylated phenylalanine grafted chitosan (Man-CS-Phe) as a possible
immunotherapeutic route for chronic hepatitis B. Within such cationic micelles, plasmid
DNA is condensed as nanosized polyplexes. As a result, the complexed DNA is shielded
against enzymatic (nuclease) degradation.
mRNA vaccine carriers: the mRNA vaccines have also found notable application
with respect to prevention of viral infections. As currently seen in the case of the COVID-19
mRNA vaccines, e.g., the one produced by Moderna, lipid nanoparticles are crucial in
effective protection against enzymatic (ribonuclease) degradation and transportation of
mRNA to cells [34]. Other than lipid nanoparticles, several new nanotechnologies have
been also devised for the sake of delivery of mRNA vaccines, Figure 4. Nanomaterial
based technologies such as dendrimers, cationic nanoemulsions, polysaccharide particles,
or liposomes have been also created to raise the stability of mRNA vaccines and optimize
their delivery mode [35].
Elia et al. [36] designed an mRNA vaccine holding lipid nanoparticle system. In this
mRNA nanocarrier, the lipid nanoparticles enclosed SARS-CoV-2 human Fc-conjugated
receptor-binding domain (RBD-hFc). After intramuscular administration of the mRNA
nanocarrier, a notable humoral reaction, a Th1-biased cellular behavior in BALB/c mice,
as well as a large extent of neutralizing antibodies were recorded. This strategy, i.e.,
encapsulating mRNA vaccine into lipid nanoparticles has been also applied in relation
to other types of viruses. For instance, Zhuang et al. [37] incorporated mRNA vaccine
(coupled with in vitro transcription (IVT)) into cationic lipid nanoparticle as an H1N1
influenza virus vaccine nanocarrier and compared its gene delivery efficiency with that of
mannose-conjugated lipid nanoparticle. As they reported, the latter nanocarrier was more
successful in this respect than its counterpart both in vivo and in vitro. The most optimum
system, IVT-mRNA-n3 loaded mannose-lipid nanoparticle was proved to be efficiently
applicable for immunization of C57BL/6 mice against H1N1 influenza virus.
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Figure 4. The as-yet studied mRNA vaccine nanocarriers. Reproduced with permission [38].
Subunit vaccine carriers: Subunit vaccines comprise very limited structural com-
ponents of SARS-CoV-2, able to induce protective immune reactions in the body, upon
administration alongside molecular supports, thereby raising immunogenicity [22]. The
subunit vaccines can be made via incorporation of viral proteins in protein cages, virus-like
particles (VLPs), and synthetic nanomaterials, performing as delivery carriers and/or
adjuvants [39–41]. For instance, influenza protein haemagglutinin incorporated liposome
is the basis of the influenza virus vaccine Crucell (Janssen, Johnson & Johnson) [42]. The
subunit vaccine nanocarriers provide antigen multivalency and allow optimum concurrent
delivery of adjuvant and antigen to secondary lymphoid organs [43]. Furthermore, thanks
to their specific size scale, they enable lymphatic trafficking and favorable uptake by the
antigen presenting cells (APCs). They induce depot effects for stable immune stimulus and
ease the antigen cross presentation, that allows the extracellular antigens to be presented
via the MHC-I pathway for CD8+ T cell engagement [44].
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2.2. Nanohybrid Materials Used for Biomedical Waste Management
As the pandemic spreads all over the world, a large number of PPE is being consumed
every day. Therefore, management of biomedical wastes is crucial to avoid an extra pressure
on the environment and spread of the virus [45]. The biomedical waste differs notably from
the normal waste considering the likely presence of pathogens on its surface that could
lead to further contamination and release of viruses and bacteria [45].
The contaminated healthcare wastes are typically discarded in landfills, thus poten-
tially might engender pollution of surface, drinking and ground water resources, in case
the landfill has been improperly designed. The healthcare wastes can be chemically treated
by chemical disinfectants, thereby further contaminating the environment via release of
hazardous chemicals into the environment. As another option, waste incineration has been
largely taken into practice. Yet, incomplete incineration could potentially pollute the air
and produce ash remainder. The other conventional methods in management of biomed-
ical waste include mechanical methods involving granulation, crushing, pulverization,
grinding, shredding, agitation, and mixing. These approaches do not necessarily eliminate
the pathogen related contaminations, but lower the waste mass thus ease its subsequent
processing or disposal. Chemical disinfection, e.g., via implementation of chlorine com-
pounds, is another popular approach to inactivate the pathogens in medical waste, and also
to oxidize harmful chemical materials. Microwave radiation and its resulting generated
heat can also potentially be utilized to treat medical waste. Thanks to detrimental effect
of gamma rays on pathogen’s DNA, gamma irradiation caused by radioactive isotopes of
cobalt, shows a high potential for sterilization of waste. However, the shadowing effect is
challenging and the waste surfaces directly exposed to the radiation source become more
sterile than those located on the shaded side [45].
Advantageous over the mentioned management techniques in terms of cost-efficiency,
sunlight based photocatalysis has been developed for both solid and liquid wastes [46].
This approach is drawing more attention for environmental remediation, considering
the demand to obtain the highest degradation efficiency of contaminants possible under
affordable conditions in terms of temperature and pressure. The main driving force in this
treatment is the near-UV light (whose wavelength varies from 400 nm down to 300 nm) that
could be even replaced by sunlight to render the technique more economical. As shown in
Figure 5a, sunlight driven photocatalysis in the presence of a nanophotocatalyst enables
release of hydroxyl radicals (OH•). Having unpaired electrons, OH• notably oxidizes the
resistant organics (e.g., pathogens) [47]. Owing to the abundance of low cost, efficient
photocatalysts, photocatalysis is of the most renowned dissociation process for organic
pollutants. This type of pollutants is easily decomposed to water and CO2 in a liquid
medium under the influence of the photocatalytic activity of a semiconductor metal oxide
nanoparticle, e.g., TiO2 [48].
Despite several advantages of the photocatalysis process for waste management
including low energy consumption, ecofriendliness with insignificant chemical input, pro-
duction of no harmful byproducts (in general least amount of secondary waste is produced),
mild operational conditions (temperature and pressure), and versatility in terms of operat-
ing medium (solid, liquid, and gas), the applicability of the process is limited due to charge
separation, interfacial charge transfer and charge carrier recombination [10,49–51]. One
promising solution for such challenges and also extending applicability of the nanopho-
tocatalysts is their hybridization with other supplementary, supportive components. For
instance, Cu-deposited TiO2 photocatalysts have been proposed to offer biocidal activity
and cooperative effect of photocatalysis and lethality of copper [52]. Such a nanohybrid sys-
tem was able to deactivate E. coli bacteria when irradiated with very weak UV light. It has
been claimed that the photocatalysis process leads to destruction of the external membrane
in the cell envelope, thereby allowing the Cu ions to get into the cytoplasmic membrane.
The copper ions damage the cytoplasmic membrane and engender the cell’s disintegration.
In general, photocatalysis can provoke degradation of simple compounds (proteins
and DNA), thereby imposing an inhibitory effect on viruses and bacteria [53]. The photo-
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catalytic detrimental impact takes place at two levels [54]: (1) Photo-inactivation ending up
with a disinfectant effect, and (2) Decomposition of viral cells bringing about a sterilizing
effect. Despite validation of effectiveness of the photocatalytic systems for virus inactiva-
tion via various laboratory experiments involving several types of microorganisms, the
antiviral mechanism is still to be understood [55–57]. The whole process seems to initiate
with adsorption of the virus on the photocatalyst surface, followed by an oxidative radical
attack on the capsid protein and on virus binding sites, aka, direct attack—redox type.
As explained in [58], the inactivation process of viruses is governed by the presence of
radicals and particularly reactive oxygen species (ROS) such as °OH, •O2−, HO2•, and
H2O2 that are available in the bulk phase and are independent of the catalyst. As similarly
mentioned for the E. coli bacteria, the decomposition process continues with destruction of
the cell wall and the cytoplasmic membrane, induced by the generation of ROS that can
result in the release of cellular content, cell lysis and eventually total mineralization of the
organism [54].
Given the same inactivation mechanism of viruses and bacteria, the photocatalytic
nanohybrids with effective antibacterial performance can potentially be applied for disin-
fection (virus removal) of biomedical wastes. For instance, CdO-MgO [59], CeO2/CdO [60],
PbS-CdO [61], CdO-NiO [62], CdO-ZnO [63], NiO-CdO [64], ZnO/MgO [65], CuO-MgO [66]
nanohybrids are some examples for the photocatalysts able to show antimicrobial perfor-
mance. In this regard, Sayadi et al. [67] devised a photocatalytic nanohybrid composed of
tungsten trioxide (WO3) hybridized with Ag doped CuFe2O4 that could offer a photocat-
alytic activity when exposed to UV/visible light and be recovered from water efficiently
thanks to the excellent photocatalytic and magnetic properties of the mentioned compo-
nents, respectively. Due to co-existence of Ag, this nanohybrid photocatalyst was able to
inactivate the E. coli bacteria when UV irradiated and after 12 h incubation, Figure 5b–e.
At the interface of the WO3 and CuFe2O4 phases (core-shell structure), the electrons sup-
plied by Ag are captured by the O2 molecules, and consequently generate reactive species
including OOH◦, O2, and HOH that optimally inactivate the bacteria.
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2.3. Nanohybrid Materials Used for Early Diagnosis of Virus Infection
To accurately diagnose the presence of viruses, advanced, reliable technologies able
to detect viruses with outstanding sensitivity are now needed more than ever. The con-
ventional PCR-based diagnosis technology, that is routinely employed for virus detection
necessitates operators and are costly in terms of equipment, challenging its implemen-
tation in the areas poor in resources [69,70]. Additionally, the technologies relying on
antigen–antibody reactions, such as immunochromatography, are not sufficiently sensi-
tive [71]. Therefore, it is indeed questionable to target accurate detection of viruses to
prevent their spread based on the techniques that are susceptible to false negatives and
false positives [72].
Thanks to the expansive specific surface area of nanomaterials, the detection technolo-
gies employing nanomaterials can potentially achieve precise analyte-specific detection
signals with superior sensitivity to even trace amounts of viruses [73,74]. In this regard,
virus detection can be optically carried out by provoking a fluorescence-raising effect
on virus when the adjacent plasmonic nanoparticles create a localized surface plasmon
resonance (LSPR) effect [75]. The as-emerging optical properties of the nanoparticles highly
depend on their interparticle spacing [76]. In addition to plasmonic nanoparticles, su-
perconductive nanomaterials can be also employed in development of highly sensitive
electrochemical biosensors for virus detection [77,78].
The Dengue virus has been similarly detected using nanohybrid optical sensors. In this
regard, the optical sensors composed of graphene oxide (GO) have drawn interest because
of their fascinating characteristics such as high density of functional groups, thinness,
negligible mass, extensive specific area, a structure providing high π-conjugation, and
optimum robustness [79–81]. The presence of a large number of functional groups on GO,
however, could be challenging with respect to its electron transfer ability, given that the
functional groups can potentially disrupt conductive zones and even the largely oxidized
GO is extremely poor in terms of electrical conductivity [82]. To resolve this issue, yet
maintaining beneficial properties, GO is typically reduced and its oxidized functional
groups are discarded, ending up with formation of reduced graphene oxide (rGO), that is
an electrically conductive material, can be stored for a longer period without agglomeration,
and is more chemical resistant (endures in the organic solvents) [83,84]. Additionally, the
residual oxygen bearing functional groups of rGO can be employed for the purpose of
chemical functionalization and creation of nanohybrid materials. As an example, rGO
can be further functionalized using primary amines (-NH2) to get hydrophilized and to
allow adhesion and binding of analytes, e.g., viruses [85,86]. In this relevance, globular
dendrimer of polyamidoamine (PAMAM) has been coupled with rGO to realize a highly
sensitive detection platform. PAMAM dendrimers are notably useful for various sensing
purposes, thanks to their efficient transporting behavior for bioactive agents and their
non-toxicity [87,88]. Omar et al. [89] devised an optical sensor, performing based on the
SPR effect, for detection of the dengue virus. The nanohybrid sensor was composed
of monoclonal antibody decorated dithiobis (succinimidyl undecanoate, DSU)/amine-
functionalized rGO–PAMAM. The as-developed sensor was able to accurately record the
alterations of the SPR angle, for instance, for the virus concentrations as low as 0.08 pM in
8 min. Interestingly, the sensor behaved selectively, and the sensitivity to other types of
proteins was lower than that to the virus. Highly conductive substrates made of graphene
have been hybridized with Au to form a sensing platform (overlaying a Au screen printed
electrode) for electrochemical detection of influenza virus. The graphene-Au nanohybrid
biosensor performs based on quantification of neuraminidase (N) activity [90].
Despite the mentioned merits, nanomaterial-based virus detectors suffer from lack of
stability and reliability of the detection signal [91]. Additionally, high sensitivity imposes a
high concern of producing nonspecific signals. To prevent generation of nonspecific signals,
thereby enabling a more reliable and stable detection process, two different signals can be
based [92]. Therefore, highly sensitive and reliable nanomaterial-based biosensors should
be developed that generate two signals. To achieve such a feature and develop a dual-signal
Polymers 2021, 13, 2833 11 of 25
virus detector, the nanomaterials able to efficiently generate and enhance electrochemical
and optical signals, such as gold nanoparticles (AuNPs) are of paramount importance [93].
In this relevance, Takemura et al. [94] have designed a novel technique for detection of the
Influenza virus based on the electrochemical and optical signals. The detection performance
tightly depends on the virus concentration. The virus detector is in fact a nanohybrid system
that comprises of: (1) plasmonic (Au) nanoparticles (AuNP) to reinforce the fluorescence
signal of CdSeTeS quantum dots (QDs) through the LSPR effect (noteworthy, the virus could
bound onto the plasmonic nanoparticles via antibody (Ab)), (2) magnetic nanoparticles
(MNP) to separate the analyte stuck within the nanohybrid structure, and (3) carbon
nanotubes (CNT), meant to act as a matrix to integrate all the components coupled with
the antibodies of the Influenza virus. The mentioned QDs suspending in the solution were
responsible for generation of the optical signal, particularly in close proximity of the Au
nanoparticles, thanks to their long fluorescence lifetime, and were able to release Cd ions at
low pHs and thereby produce an electrochemical signal, Figure 6a. In more precise words,
when the QD–Ab/virus/Ab–AuNP–MNP–CNT nanoassembly is dissolved at a low pH,
the Cd ions are released from the QDs, whose concentration is quantified electrochemically
by the AuNP–MNP–CNT-deposited carbon electrode.
Figure 6. (a) Schematic illustration of the optical/electrochemical detection process of the Influenza virus based on imple-
mentation of plasmonic nanocomposites and quantum dots. Reproduced with permission [94], Copyright 2021, American
Chemical Society. The improvement of the PCR efficiency (nano-PCR based on pan-type primers) through inclusion
of GO-AuNPs at different concentrations for the purpose of quantification of FMDV O-type (b) and FMDV A-type (c).
Reproduced with permission [95].
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As mentioned earlier, despite popularity of PCR as a detection technique for viruses,
it suffers from poor specificity, insufficient sensitivity, and generation of false positive
results. To address such shortcomings, metal and carbon nanomaterials are included to
raise the quality of performance of PCR assays. Kim et al. [95] enhanced the capability of
PCR using a nanocomposite made of GO sheets (as the matrix) and AuNPs (~15 nm) to
enable sensitive diagnosis of the foot-and-mouth disease virus (FMDV), which leads to a
drastically infectious and fatal viral disease for the animals with cloven-hoof such as pigs,
and thus negatively impacts on the swine industry. As validated by the authors, the limit
of detection (LoD) of real-time PCR upgraded by GO-AuNPs raised up to ~1000 times.
The improvement in the PCR detection efficiency was determined via comparison of DNA
amplification potential in the presence (at various concentrations) and absence of GO-
AuNPs. As shown in Figure 6b, the optimal concentration was proved to be ~10 µg/mL,
particularly, 20 µg/mL of GO-AuNPs led to a notable decline in signals. It is known that
GO-AuNPs can electrostatically attach to single-stranded DNA (ssDNA) in a selective
manner [96]. As a result, the quality of PCR performance is notably enhanced when
acting as a single-stranded DNA binding protein (SSB), optimizing the interaction between
templates and primers while DNA replicates in vivo. On the other hand, larger GO-AuNPs
concentrations could potentially impede the PCR reaction, due to their tendency to bind to
double-stranded DNA (dsDNA), rather than to ssDNA.
2.4. Nanohybrid Materials Used for Viral Infection Therapy
Nanohybrids benefitting from a therapeutic agent coupled with a supportive or-
ganic/inorganic nanomaterial have shown promising applicability for treatment of various
viral infections caused by Influenza, Hepatitis C, and SARS-CoV-2.
Influenza A virus (IAV) is accounted as an important infectious pathogen in relation
to humans and animals and frequently engenders epidemics and epizootics. Annually,
influenza infects around 100–500 million people, thereof almost 500,000 die [97,98]. The ex-
clusive structure of this virus, with respect to genome fragmentation (the genome comprises
eight negatively charged segments of single-stranded RNA) and glycoproteins diversity,
is the main ground for its global spread. As a consequence of gene recombination and
antigenic shift, new variants of the Influenza virus emerge and bring about pandemics and
epidemics [99]. To address the global challenge caused by the spread of Influenza, only a
limited variety of drugs with selective performance such as neuraminidase inhibitors (e.g.,
oseltamivir) and adamantane drugs are available that could even drive the formation of
resistant IAV strains and side effects [100]. Therefore, there is a demand for development
of new therapeutics that can deactivate the influenza virus in an effective manner. In this
regard, the nucleic acid fragments that can identify the target nucleic acids selectively,
thereby minimizing adverse side effects in comparison to non-specific traditional drugs,
are promising candidates. Despite such merits, these therapeutics have not found extensive
application mainly due to their poor serum stability and their challenging diffusion into
cells. To address the former bottleneck, i.e., stabilization of oligonucleotides, chemical
treatment has been proved to be efficient [101]. On the other hand, liposomes, virus vectors,
cationic polymers, transporting peptides, among others can act as carriers to ease and
improve delivery of oligonucleotides [102–104]. However, even the most successful deliv-
ery approach is not efficient enough and might impose toxicity. To advance this research
area and to meet the need to effective delivery systems, Levina et al. [99] proposed a new
platform able to deliver nucleic acid fragments (ODN) into eukaryotic cells based on a
nanocomposite material. The nanocomposite comprised of ODN loaded polylysine that
was non-covalently immobilized onto TiO2 nanoparticles. The selected nanoparticles are
biocompatible and non-toxic and enable the ODN delivery via the cell membrane [105,106].
Moreover, they stabilize and protect the ODN against intracellular enzymes [107]. Upon
entry into cells, the carried oligonucleotides are released from the nanocomposites in the
cytoplasm or penetrate into the nuclei and bind to the RNA molecules [108]. As veri-
fied via in vitro tests, the nanocomposites induce no toxicity reaction, readily enter into
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the eukaryotic cells, and significantly deactivate 3 IAV subtypes, e.g., hazardous H5N1
avian influenza.
Hepatitis C virus (HCV) is another important virus affecting more than 58 million peo-
ple worldwide and resulting in severe liver disease [109]. Thanks to further comprehension
of the biology of HCV as well as identification of antiviral targeting of vital functions of the
virus, the relevant treatments are being advanced and becoming more efficient [110]. In
this regard, the NS3 and NS5A proteases and NS5B polymerase are regarded as important
targets for the creation of direct-acting antiviral drugs [111]. The standard therapy for the
HCV genotype 4a comprises ledipasvir, ombitasvir, and sofosbuvir with a response rate of
over 90% [112]. Although this treatment has shown considerable promises, its efficacy is
below optimum and undesired consequences such as photosensitivity, pruritus, rash, ane-
mia, etc. [113] could potentially emerge. Additionally, the rising number of patients who
suffer from dangerous liver diseases with no proper treatment choice further highlights
the importance of development of suitable therapeutic approaches. Challenging fulfilment
of this objective, viral RNA is rapidly mutated and thereby creation of state-of-the art anti-
HCV drugs are hampered. One promising solution for treatment of the HCV infections is
indeed the use of plant derived natural compounds that show relevant antiviral perfor-
mance [114]. Furthermore, such compounds exhibit hepatoprotective effect due to their
natural substances including caffeine, naringenin, silymarin, and epigallocatechin-3-gallate
(EGCG) [115,116]. As an example, for the plant-derived antiviral compound, turmeric cur-
cumin, aka, curcuma longa, has shown promising therapeutic efficiency with no particular
side effects [117]. Curcumin offers antiviral effect against hepatitis B virus [118], influenza,
human herpes, and HIV viruses [119]. As reported by Pecheur [120], curcumin can also
deactivate HCV through challenging the viral adhesion and fusing to hepatocytes and
inhibiting intercellular transmission by damaging the membrane’s structure. Nevertheless,
curcumin is poorly soluble and hardly penetrated into cells. One solution to overcome
such problems, is the use of polymeric nanoparticles as a carrier for curcumin, that assures
its steady release to infected cells and its bioavailability, and hampers its degradation,
thereby enhancing its therapeutic capacity [121]. In this regard, biocompatible polymers
originating from nature are highly demanded. For instance, chitosan, a derivative of chitin,
is a natural biopolymer (polysaccharide) and after cellulose is ranked the second most
available polysaccharide in nature [122]. Chitosan shows immunogenicity, and anticancer,
antimicrobial, and anti-inflammatory effects [123]. Chitosan nanoparticles are non-toxic
at low dosages (30 µg/mL) and offer an anticancer effect at high dosages (>100 µg/mL).
These promising potentials encourage its implementation as a drug carrier [124,125]. In this
regard, Ramana et al. [126] employed chitosan nanoparticles as a carrier for antiretroviral
agents such as saquinavir, that is a protease inhibitor, to deactivate HIV. By this strategy,
cell targeting efficiency raised up to 92% in comparison with that of the soluble drug alone.
In another study, Loutfy et al. [127] studied the antiviral efficiency of curcumin-chitosan
nanocomposite against HCV-4 in silico, involving the hepatoblastoma cells. According to
their results, the nanocomposite system is able to notably reduce the HCV core protein
expression, as verified by the Western blot assay. Such reduction was much superior in the
case of the nanocomposite as compared to the controls including curcumin and chitosan
nanoparticles, implying its extraordinary antiviral effect via blocking the penetration or
replication of virus. Though, the achieved results clearly demonstrate the applicability
of the nanocomposite against viral infection, the anti-HCV effect of the nanocomposite
in the replicating system and its therapeutic index need to be evaluated. Moreover, the
nanocomposite carrier should be also precisely tested in vivo.
In addition to the aforementioned drug-based antiviral therapies, photodynamic
therapy (PDT) is an efficient strategy to deactivate viruses including SARS CoV-2. In this
approach, the target cells are attacked when photosensitive agents, aka, photosensitizers
(PSs), are excited by light irradiation and thereby produce reactive oxygen species (ROS)
that are fatal to cells [1]. In fact, ROS seriously damages the nucleic acids and proteins of
virus [128]. Figure 7a shows the mechanism of generation of ROS by PSs. Majority of PSs in
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their ground (i.e., singlet) state possess 2 electrons, spinning oppositely in a molecular orbit
with the most optimum energetic level. Upon light absorption, one of these electrons jump
to an orbit with a higher energy state. As a result, the PS becomes extremely unstable and
starts to emit the extra energy in the form of heat and/or fluorescence. As a second scenario,
the PS after excitation might experience an intersystem crossing, thereby forming a triplet
state with higher stability where one electron inversely spins. To revert to the ground state,
the PS should either lose energy without emitting radiation or passing the extra energy
on molecular oxygen (O2), ending up with generation of 1O2 (Type II process) [129]. PS
can also react with an organic substance within a cellular medium, whereby it receives an
electron or a hydrogen atom and converts to a radical (Type I process). The as-reduced PS
is subsequently autoxidized and releases a superoxide anion radical (O•−2 ). The generated
radical undergoes one-electron reduction thereby forming hydrogen peroxide (H2O2), that
is subjected to one-electron reduction, leading to creation of a highly oxidative hydroxyl
radical (HO•). It is thought that majority of PSs perform through Type II process to generate
ROS [130].
Figure 7. (a) The mechanism of photosensitization as described through a Modified Jablonski Diagram. Upon light
irradiation, a photosensitizer (PS) molecule undergoes a transition from the ground singlet state (S0) to a provoked singlet
state (S1). At S1 the molecule might experience intersystem crossing towards an excited triplet state (T1). Subsequently, it
either creates radicals (Type I process) or pass its energy on a molecular oxygen (3O2), forming singlet oxygen (1O2), i.e., the
main cytotoxic substance taking part in PDT. In the diagram, ns, µs, nm, and eV represent nanoseconds, microseconds,
nanometers, and electron volts, respectively. (b) The schematic illustration of PDT for cancer therapy, where a PS is
distributed topically or systemically within body. Over time, PS is selectively accumulated in the tumor and then by
irradiation is excited. Subjected to molecular oxygen, a photochemical process is carried out that leads to formation of
singlet oxygen (1O2). Severe destruction of cellular macromolecules causes the cell death of tumor through a necrotic,
autophagic, or apoptotic process, that is complemented with inflammation. An acute local inflammatory process eliminates
the dead cells and restores normal tissue homeostasis. Reproduced with permission [130], Copyright 2011, American
Cancer Society.
PDT was for the first time in 1970s used for the purpose of deactivation of viruses [131].
Beforehand, it was mainly employed for clinical treatment of different oncological disorders,
Figure 7b [130]. With respect to virotherapy, PDT has shown applicability against herpes
simplex virus, human immunodeficiency virus, and human papilloma virus [128,131,132].
However, some challenges regarding the PSs including their typical hydrophobicity, leading
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to their aggregation in water-based solutions, lack of target specificity, and also insufficient
penetration into the desired tissue have notably restricted clinical application of PDT [1].
To resolve such issues, Lim et al. [133] developed sodium yttrium fluoride (NaYF4) upcon-
version nanoparticles surface decorated with zinc phthalocyanine PSs. To hydrophilize the
nanohybrid, the nanoparticles were coated with polyethylenimine (PEI). Such a nanohybrid
was able to deactivate adenovirus type 5 and Dengue virus serotype 2, representative of
nonenveloped and enveloped viruses, respectively. Curcumin loaded liposome is another
nanohybrid system developed to inactivate viruses (papillomavirus) through release of
curcumin alongside PDT [134]. In this system, liposomal encapsulation enables optimal,
targeted delivery of curcumin to cells. On the other hand, curcumin liposomes were able
to induce a PDT (phototoxic) effect thus cell death in the papilloma virus-related tumor
cell lines.
Another relevant approach is photobiomodulation therapy (PBMT), i.e., the light ther-
apy based on non-ionizing types of light sources such as laser, that could be employed with
or without application of a static magnetic field (sMF) [135,136]. Severe cases of COVID-19
arise when immune response in the patient’s body is insufficient and pro-inflammatory
cytokines are extensively released and harm different organs such as lungs. As a supportive
therapeutic strategy, PBMT utilizing a low-level laser (LLLT) raises immunity, stimulate
tissue regeneration and decline pro-inflammatory cytokines [135]. De Marchi et al. [137]
studied the treatment of the patients suffering from severe COVID-19, who were in the
need of mechanical ventilation, through PBMT-sMF. As they reported, PBMT-sMF could
enhance the ventilatory parameters and improve the immune response. Conclusively,
PBMT-sMF or LLLT may show a proper therapeutic effect, thereby reducing the medical
burden imposed on the healthcare systems and alleviate the application of inadequate
medicinal resources during the COVID-19 pandemic.
2.5. Nanohybrid Materials Used as Antiviral Coatings
In order to decline the chance of spread of viruses, we need to cut off their transmission
routes by applying antimicrobial nanomaterials on the surfaces and creating antiviral
coatings. In this regard, different antiviral metal ions including Au, Ag, and Cu, and metal
oxides, antiviral polymers, and new antiviral nanomaterials have been studied to be used
as virus inactivating coatings [138–143].
Polymer nanohybrids based on inclusion of antiviral agents in a polymeric nanoma-
terial and its later controlled release have been used for antiviral coatings. In this regard,
metal oxides and nanoparticles are widely employed in construction of antiviral polymeric
coatings. For instance, Karagoz et al. [144] synthesized nanohybrid nanofibers with antivi-
ral and self-cleaning performance based on surface deposition of Ag nanoparticles and
ZnO nanorods onto poly(methyl methacrylate) (PMMA) nanofibers, Figure 8a–c. Such
nanohybrid nanofiber mats could offer excellent potential for protective clothing, Figure 8d,
thanks to their promising antiviral performance against coronavirus and influenza virus,
antibacterial activity for Gram-negative and -positive bacteria, and photocatalytic decom-
position of organic pollutants, Figure 8e,f. Additionally, they provide a substrate allowing
surface-enhanced Raman scattering (SERS) for the purpose of quantification of impurities
mounted on the mat (fabric), Figure 8g. In another study, Tremiliosi et al. [145] synthesized
Ag nanoparticle incorporated polycotton fabrics to reduce transmission of SARS-CoV-2.
As will be discussed a bit later, Ag nanoparticles offer outstanding inactivation potential
for pathogens and for this reason they are extensively employed in the textile industry.
According to the results of this study, the proposed polymeric nanohybrid could optimally
inactivate the SARS-CoV-2 virus (~100% in only 2 min), E. coli and S. aureus bacteria, and
Candida albicans with no particular allergic reactions. Aligned with the use of natural poly-
mers, alginate has been also used as a matrix for an antiviral nanohybrid system. Calcium
alginate is well-known for its antiviral behavior against the enveloped double-stranded
DNA herpes simplex virus type 1 [146]. To extend applicability of calcium alginate to
non-enveloped double-stranded DNA viruses, carbon nanofibers (CNFs) have been added
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as a filler [147]. Recalling the promising antiviral activity of carbon nanomaterials, e.g.,
GO, against RNA and DNA viruses including pseudorabies virus and porcine epidemic
diarrhea virus, the CNF/alginate benefits from a superior, synergetic antiviral performance
originated from each constituent. It is believed that alginate’s negative charge is respon-
sible of its antiviral activity [148] and hampers the decapsulation of the non-enveloped
virus protein on the cell membrane’s surface [149]. Additionally, CNFs are also negatively
charged and this charge is maximized due to their extremely large surface area [150–153].
This feature notably contributes to the overall surface charge of the nanohybrid and thereby
notably inactivates the virus. In general, the nature-derived polymers with antimicrobial
properties have been demanded considering their biocompatibility and abundance. In
addition to cotton and alginate mentioned earlier, shellac has been also employed as a
constituent of an antiviral nanohybrid. In this regard, Kumar et al. [154] developed a
nanohybrid antiviral coating made of shellac/Cu nanoparticles that could be applied to
nonwoven surgical masks, Figure 9a,b, to raise hydrophobicity, thereby avoiding adhesion
of aqueous droplets. Additionally, the nanohybrid surface induced high photoactivity (a
combination of photothermal and photocatalytic properties) that could provoke antimi-
crobial activity and enable self-sterilization and reusability of the masks. Exposed to solar
light, the temperature of the mask promptly increases up to over 70 ◦C, thereby releasing
a large number of free radicals that potentially damage the virus membrane, Figure 9c.
Figure 9d,e show a general image of the photoactive antimicrobial mask (PAM) and the
SEM images of its nonwoven fibers before and after coating with the antiviral nanohybrid.
Figure 9f implies the hydrophobicity of the mask fibers after coating that could potentially
prevent adhesion of the virus containing droplets on the mask surface.
An antiviral nanohybrid system comprising metal nanoparticles and metal oxides
could be also applicable with respect to absorption of virus aerosols and inactivation of
viruses. In this regard, Balagna et al. [155] developed an antiviral nanohybrid coating
made of Ag nanoclusters/silica that could be deposited on metallic, glass, and cotton
filters via co-sputtering. The as-made coatings showed a remarkable antiviral performance
against respiratory viruses such as human rhinovirus and influenza A, while maintaining
the filtering function. Such coatings can be suggested for modification of the masks and
filters being used in gyms, hospitals, and anywhere that is exposed to the spread of
viruses. Ag has been already recognized as an important antifungal and antibacterial
material [156], and recently its antimicrobial effect has been extended to viruses [157]
including adenovirus type 3 (Ad3) [158] and H1N1 influenza A virus [159]. Figure 8h–k
shows how the Ad3 virus particles are damaged in the presence of Ag nanoparticles over
a time period of 120 min. Further to the air filters coated with Ag nanoparticle/silica
particles, Joe et al. [160] succeeded to verify that the as-developed nanohybrid system is
able to show a promising antiviral effect against aerosolized bacteriophage MS2, while
preserving the filtration efficiency.
Graphene, which is a two-dimensional (2D) one-atom-thick planar sheet of carbon
atoms inter-sp2-bonded, is advantageous over classic nanomaterials in terms of extraordi-
nary large surface area, carrier mobility, biocompatibility, and optical transparency [83].
Graphene exists in several forms of pristine graphene, graphene oxide (GO), and also
reduced graphene oxide (rGO). Previously, the antibacterial potential of GO nanosheets
has been validated through several relevant studies [161–163]. Additionally, it has been
reported that graphene nanomaterials are able to block penetration and replication of RNA
virus (coronavirus) and enveloped DNA virus (herpesvirus) in the target cells [164,165].
Synergistically, GO sheets alongside Ag nanoparticles form antimicrobial nanohybrids that
can inactivate bacteria and viruses. In such nanohybrid systems, the GO sheets play a
supportive/stabilizing role and hamper agglomeration of the nanoparticles and thus main-
tain the antimicrobial potential. As reported by de Faria et al. [161] the Ag nanoparticles
mounted on GO sheets are spherical and as small as 7.5 nm, assuring their applicability for
antiviral purpose. Thanks to the presence of GO sheets, the immobilized Ag nanoparticles
are unable to displace and endanger the biocompatibility of the developed system. This
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feature minimizes the toxicity and the environmental hazards related to such nanoparticles.
Additionally, the nanohybrid is notably water dispersible, possesses an extensive surface
area, and offers outstanding antibacterial capacity at negligible amounts. Chen et al. [166]
synthesized a nanohybrid comprised of Ag nanoparticles loaded GO sheets and investi-
gated its antiviral potential against the feline coronavirus (FCoV; an enveloped virus) and
infectious bursal disease virus (IBDV; a non-enveloped virus). As the authors report, the
GO-Ag nanohybrid hampered 25% of the FCoV related infection and 23% of the IBDV
caused infection. While, neat GO inhibited only 16% of the FCoV related infection and was
ineffective against the infection arisen by IBDV. The as-developed GO-Ag nanohybrid can
be potentially applied in construction of PPE to minimize virus transmission.
Figure 8. Schematic demonstration of the fabrication process of ZnO–Ag/PMMA nanofiber: (a) hydrothermal synthesis
of ZnO nanorods. The inset image represents their morphology, (b) production of the electrospinning solution through
addition of ZnO nanorods and PMMA to the AgNO3/DMF solution wherein Ag nanoparticles form via in situ reduction
of the Ag salt, (c) creation of the ZnO–Ag/PMMA nanofibers through electrospinning, (d) the mats comprising the ZnO-
Ag/PMMA nanofibers are employed as a protective clothing, and offer antimicrobial (e), photocatalytic (f), and sensing (g)
properties. Reproduced with permission [144], Copyright 2021, American Chemical Society. TEM images show how the Ag
nanoparticles adversely affect the Ad3 particles at different intervals. (h) Control sample in the absence of Ag nanoparticles;
the samples treated with Ag nanoparticles (50 µg/mL) for 30 min (i), 90 min (j) and 120 min (k). As clearly observed, the
capsid and the whole virus particle have been notably destructed in the presence of the nanoparticles. Reproduced with
permission [158] Copyright 2013, Elsevier.
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Figure 9. Schematic illustration of: (a) the antiviral nanohybrid coated surgical masks, (b) the dual-channel spray coating
process on the nonwoven fibers of the surgical mask, whereby the Cu nanoparticle suspension and shellac are mixed
and sprayed via the compressed N2 air channel, and (c) the solar light driven inactivation of the viruses available in the
respiratory droplets. (d) Camera image of the photoactive antiviral mask (PAM). (e) SEM images show the morphology of
propylene nonwoven fibers (left) in the commercial surgical mask and the nanohybrid-coated nonwoven fibers in the same
mask (right). (Scale bar represents 10 µm). (f) Camera images of a dyed water droplet deposited on the uncoated mask
and PAM after one hour. Reproduced with permission [154], Copyright 2021, American Chemical Society. (g) Schematic
illustration of likely interactions between SARS-CoV-2 and graphene (GR) and GR nanohybrids comprising GR-metal ion,
leading to virus inactivation on the coated surfaces. Reproduced with permission [167], Copyright 2020, Elsevier.
In general, GO nanomaterials exhibit a wide range of antiviral activities against
DNA and RNA viruses, non-enveloped and enveloped viruses, and negative and positive
sense viruses, thus offering promising potentials for generation of advanced antiviral
coatings. In particular, knowing that the SAR-CoV-2 virus’ structure possesses a plethora of
carboxyl groups and the virus hardly survives on the Cu surfaces, the coatings composed
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of GO/rGO-SO3 incorporated with Cu nanoparticles/ions could potentially inactivate the
SARS-CoV-2 viruses. Other nanohybrids based on GO/rGO-SO3 doped with Ag, Ti, and
Au could also be suggested for construction of antiviral coatings. As shown in Figure 9g,
such materials optimally capture and destabilize the viral particles and thereby lower their
survival chance when located on the antiviral coating [167]. In this regard, Van der Waals
and electrostatic interactions are decisive in capturing the viruses and the sharp edges of
the graphene plates disrupt the virus membrane, thereby killing the virus.
3. Conclusions and Future Perspective
The Covid-19 pandemic made us all encounter unpredicted challenges. Despite loss
of many humans and irreversible damages to human society, this crisis had a second face
of coin. It made us think how to prepare ourselves in the future for other likely virus
pandemics. It taught us how to progress in science despite time and resource limitation and
how to further consider the natural sources in dealing with such a crisis. Bioinspiration and
employment of natural materials to cope with a natural crisis have advanced notably. Now,
we mimic the structure and function of viruses to fight with them. The newly emerged
vaccine systems that are in fact biohybrids in nanoscale are one of the mind-blowing
achievements of human kind that was driven by surge of viral infections across the world.
Now, we know that in the future we need multifunctional, bioinspired weapons against
viruses. To meet this need, materials science and biology are coupled to generate a new
generation of multifunctional and environmentally friendly nanohybrids that not only
inactivate viruses, but also prevent their transmission and surface adhesion. Antiviral
coatings are crucial to prevent the spread of viruses. On the other hand, the packaging
materials that can show antimicrobial activity are highly demanded for disinfection of
microorganisms. Furthermore, for the purpose of development of antiviral fabrics for PPE
and household masks, antiviral nanohybrids will play a critical role.
In a broader perspective, we must seek advanced approaches guaranteeing health, but
with consideration of the “One Health” concept, that stresses on the fact that the well-being
of humans is tightly connected to that of other creatures and environment [1]. To tackle this
intricate challenge, multidisciplinary researches involving scientists with complementing
expertise are highly needed. The current crisis should be thought as a great opportunity to
make us think about our globalized world and encourage us to take multi/interdisciplinary
methodology more seriously. In this regard, transversal disciplines should be involved and
the knowledge exchange and diversity in scientific point of views should be considered vital
to create new, advanced scientific solutions. In this context, nanotechnology, particularly
involving multifunctional nanohybrids, is a fertile area wherein researchers with different
backgrounds can cooperate to address the complex problems. This frontline discipline is
needed now more than ever to create new pillars toward resolving the current global public
health issues, to weaponize us for the likely upcoming health challenges (e.g., infectious
diseases), and to help us further consider sustainable scientific solutions.
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